Table 3 Response to exercise training and traditionaly rehabilitation in patients with STEMI evaluated by ergometry, exercise echogardiography, exercise spiroergometry and BNP (brain natriuretic peptide)
t0 | t1 | p+ | t2 | p# | p§ | |
|---|---|---|---|---|---|---|
Flow cytometry analysis | ||||||
CD45 +/ CD34 + cells, n | ||||||
exercise training | 257 ± 102 | 302 ± 128 | 0.022 | 269 ± 117 | n.s. | n.s. |
controls | 275 ± 68 | 254 ± 66 | n.s. | 268 ± 69 | n.s. | n.s. |
p | n.s. | n.s. | n.s. | |||
CD45 + /CD133 + cells, n | ||||||
exercise training | 64 ± 26 | 88 ± 46 | 0.023 | 68 ± 32 | 0.0 18 | n.s. |
controls | 73 ± 22 | 58 ± 19 | 0.075 | 72 ± 23 | n.s. | n.s. |
p | n.s. | 0.0 60 | n.s. | |||
Migration capacity | ||||||
Cytokine SDF-1, % | ||||||
exercise training | 113 ± 12 | 199 ± 57 | < 0.001 | 130 ± 37 | < 0.001 | 0.055 |
controls | 127 ± 30 | 128 ± 41 | n.s. | 112 ± 10 | n.s. | n.s. |
p | n.s. | < 0.001 | n.s. | |||
Cytokine VEGF, % | ||||||
exercise training | 121 ± 19 | 242 ± 95 | < 0.001 | 134 ± 44 | < 0.001 | n.s. |
controls | 142 ± 45 | 134 ± 44 | n.s. | 110 ± 12 | 0.0 60 | n.s. |
p | n.s. | < 0.001 | n.s. | |||
Clonogenic potential | ||||||
CFU-erythroid, n | ||||||
exercise training | 50 ± 33 | 46 ± 33 | n.s. | 39 ± 28 | n.s. | n.s. |
controls | 84 ± 51 | 52 ± 53 | 0.058 | 26 ± 29 | n.s. | 0.009 |
p | 0.065 | n.s. | n.s. | |||
CFU-granulo./macrophage, n | ||||||
exercise training | 13 ± 9 | 12 ± 7 | n.s. | 18 ± 15 | n.s. | n.s. |
controls | 23 ± 16 | 14 ± 12 | n.s. | 7 ± 7 | n.s. | 0.092 |
p | 0.095 | n.s. | 0.0 27 |